According to Apellis Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -$0.53 B. In 2022 the company made an earning of -$0.66 B an increase over its 2021 earnings that were of -$0.75 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.53 B | -19.19% |
2022 | -$0.66 B | -12.67% |
2021 | -$0.75 B | 117.47% |
2020 | -$0.35 B | 12.58% |
2019 | -$0.31 B | 139.78% |
2018 | -$0.13 B | 149.14% |
2017 | -$51.01 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$0.12 B | -78.96% | ๐บ๐ธ USA |